Categories
Medicare For All

Time to Take to the Streets to Demand Medicare for All!

Sanders, Jayapal Put Single Payer Medicare for All on Back Burner, Corporate Crime Reporter, May 10, 2021, By Russell Mokhiber

Single payer activists want Medicare for All front and center in Congress.

But Senator Bernie Sanders and Congresswoman Pramila Jayapal have put the issue on the back burner.

Sanders has yet to reintroduce his single payer legislation in the Senate. 

Instead, Sanders is pushing for a step by step approach – dropping the Medicare age to 60 and expanding it to cover dental, hearing and vision.

This step by step approach is justified by Sanders supporters like Michael Lighty who wrote recently that “Medicare for All isn’t yet winnable – expansion is.” 

And while Congresswoman Jayapal introduced her Medicare for All legislation (HR 1384) in March, she made it clear that she was more interested in the Sanders step by step approach.

Inside the beltway progressives refuse to challenge Sanders and Jayapal.

But Kay Tillow of The All Unions for Single Payer Health Care in Louisville, Kentucky says that the step by step approach won’t work.

And she questions why Sanders and Jayapal didn’t just re-introduce HR 676, the original single payer proposal in the House.

Tillow wrote to Jayapal at the end of December 2020 with her concerns…

“We are deeply concerned that HR 1384, the bill that succeeded Congressman John Conyers’ HR 676, dropped some of the key principles that were in Conyers’ model single payer bill,” Tillow wrote to Jayapal. 

“There is no reason for any compromises to be made at this point. We need model legislation that sets the stage for the struggle that is to come. If a principle is not placed on the table at the beginning of the bargaining, it is conceded. Unionists know that the outcome does not improve in the negotiations. The effort for the integrity of the single payer model in actual legislative form needs to be made.”

***

Comment by Don McCanne

Bernie Sanders, Pramila Jayapal, and Michael Lighty – heroes of the single payer Medicare for All movement – are also political pragmatists. But Kay Tillow is a political realist. “If a principle is not placed on the table at the beginning of the bargaining, it is conceded. Unionists know that the outcome does not improve in the negotiations.”

Recent media reports have indicated that our heroes recognize the political barriers to reform and are now posturing with the view that we should support beneficial measures that may not get us all the way there. Perhaps the most prominent isolated policy that is gaining support is lowering the eligibility age for Medicare – a view that some think that President Biden may eventually agree to as a compromise.

Where are the insurers and the medical-industrial complex on this? Of course, they are opposed. But are they really? Almost half of Medicare has already moved into the private insurance Medicare Advantage plans. Since some believe that Medicare for All is inevitable, what better strategy could they have than to complete the conversion to private Medicare Advantage for All? That concept is sneaking into the health policy literature, and it certainly wasn’t us who put it there.

Oh, you say, that won’t happen because we will be able to follow up with the Medicare public option. But isn’t that just another insurance plan that will be plugged into the Medicare Advantage insurance exchange?

Never fear. We are being told that President Biden has proven to be a great progressive like Franklin Delano Roosevelt. But wasn’t it FDR who threw health insurance out of the Social Security Act?

Kay Tillow has warned us that we can’t take anything off of the table, but we already have, and we are poised to take much more off.

Instead, we should be taking to the streets screaming for health care justice for all. Listen… silence. We have to change that. Now!

Categories
Medicare For All

Guarantee Coverage for All Medically Necessary Services – Including Reproductive Care

Supreme Court to review Mississippi abortion law that advocates see as a path to diminish Roe v. Wade, Washington Post, May 17, 2021, By Robert Barnes

“The Supreme Court announced Monday that it will review a restrictive Mississippi law that provides a clear path to diminish Roe v. Wade’s guarantee of a woman’s right to choose an abortion.

Abortion opponents for months have urged the court’s conservatives to seize the chance to reexamine the 1973 precedent. Mississippi is among many Republican-led states that have passed restrictions that conflict with the court’s precedents protecting abortion rights, hoping for a chance to get a case before a Supreme Court that they think is more amenable to their arguments.

In accepting the case for next term, the court said it would examine whether “all pre-viability prohibitions on elective abortions are unconstitutional.” That has been a key component of the court’s jurisprudence, and the announcement sounded ominous to abortion rights advocates.”

The incomplete promise of Medicaid expansion, Vox, May 17, 2021, By Dylan Scott 

“In November, Missourians voted to expand Medicaid under the Affordable Care Act, granting access to health insurance to roughly 230,000 people living in poverty. Now the state’s Republican legislators are defying the will of their voters by refusing to implement the expansion.

In late April, the Missouri Senate blocked funding for Medicaid expansion. Last week, Gov. Mike Parsons cited the lack of funding to justify withdrawing the expansion plan entirely.

The pattern demonstrates that, nearly a decade after the Supreme Court ruled that states could choose whether to expand their Medicaid programs, the fight over whether to do so is far from over. So far, 38 states and Washington, DC, have expanded Medicaid, covering nearly 15 million people. In the dozen states that have not, 4 million people are uninsured who would receive Medicaid coverage if their state expanded eligibility under the ACA. More than 95 percent live in the South, they are disproportionately Black, and many are not eligible for subsidies to buy private coverage on the ACA markets.”

***

Comment by Eagan Kemp

While these two stories may not initially seem linked, Medicare for All supporters know that they both highlight just how tenuous access to health care remains when subject to the whims of states. Numerous states continue to fail their residents by refusing to expand Medicaid and also by attempting to restrict access to reproductive services, especially abortions. 

The answer to both of these problems is Medicare for All, which would guarantee coverage for all medically necessary services, including abortion and the full spectrum of reproductive health care services, and ensure that everyone in the U.S. can finally get the health care they need, regardless of where they live. 

Failure to pass Medicare for All and end the Hyde Amendment that sharply limits federal funding for abortion means that states can restrict health care access. If the Supreme Court overturns or severely curtails the protections provided by Roe v. Wade, many states would pass even more restrictive provisions inhibiting the right to choose. Many of the same states continue to refuse to expand Medicaid, even when approved in a referendum by a majority of state voters, as is in Missouri. 

This situation will place many pregnant women in a catch-22: both unable to afford the massive medical bills that come with pregnancy because they cannot access Medicaid (which pays for >40% of pregnancies nationwide), and unable to seek a legal abortion.

The time has come to protect reproductive rights from reactionary state forces, reverse the Hyde Amendment, and finally ensure that everyone in the U.S. can get the care they need when required. It’s time for Medicare for All.

Categories
Profits

Hospital and Group Practice Profit Motive Poses as Big a Threat as Insurers

Recent Changes in Physician Practice Arrangements: Private Practice Dropped to Less Than 50 Percent of Physicians in 2020, AMA Economic and Health Policy Research, May 2021, By Carol K. Kane

“2020 was the first year in which less than half (49.1 percent) of patient care physicians worked in a private practice—a practice that was wholly owned by physicians. This marks a drop of almost 5 percentage points from 2018, when 54.0 percent of physicians worked in physician-owned practices, and a drop of 11 percentage points since 2012. In 2020, almost 40 percent of physicians worked directly for a hospital or for a practice at least partially owned by a hospital or health system.

The shift toward larger practice size, which has been ongoing for many years, also appears to have accelerated between 2018 and 2020. The percentage of physicians in practices with at least 50 physicians increased from 14.7 percent in 2018 to 17.2 percent in 2020.

Fifty percent of physicians were employed, 44.0 percent had an ownership stake in their practice, and 5.8 percent were independent contractors in 2020. The employee percentage was up from 47.4 percent in 2018 and 41.8 percent in 2012.”

***

Comment by Steffie Woolhandler and David Himmelstein

The rapid shift from private practice to employment by large corporate organizations – a shift that’s even more marked among doctors under 40, 70% of whom were employees by 2020 – has important implications for health care reform. Insurers’ profit-seeking is the main threat to the clinical independence of doctors in private practice. But pressure from employers seeking to bolster their bottom line is an additional threat – sometimes the main one – for those whose paycheck comes from a hospital, health system, group practice or private equity firm. Private practitioners lose income if they offer free care to an uninsured patient, open their practice to Medicaid patients who bring scant reimbursement, or advise patients to hold off on undergoing a lucrative procedure. Employed doctors risk losing their jobs for repeated offenses against their organization’s profitability.

Hence, this latest AMA survey data highlights the importance of eliminating profit incentives that bend clinical priorities in both non-profit and for-profit health care institutions. For-profits should be banned, as Medicare used to do in its home care program. Non-profits should be paid global operating budgets and prohibited from retaining any surpluses or using the money not spent on patients for outrageous executive compensation or profit-based bonuses for employees.

Categories
Pharmaceutical

Learning from COVID-19: Public Funding of Drug Development

The covid-19 vaccine patent waiver: a crucial step towards a “people’s vaccine”, BMJ blog, May 10, 2021, By Gregg Gonsalves and Gavin Yamey

“An IP waiver would allow other producers to step in and make raw materials for export for all the current vaccines, industrial parts, and components. It would also simplify agreements for eventual production of more doses. But an IP waiver alone will not solve the covid-19 vaccine access challenge. Two further steps will need to be taken to reach a people’s vaccine. Step two is a transfer of technical know-how from vaccine makers in the global north to regional hubs or directly to manufacturers in the global south. Step three is vast subsidization of manufacturing in LICs and LMICs. 

Thousands of lives can be saved immediately through a donation model. But at the same time, we need to get going now on a people’s vaccine, since the ramp-up of vaccine manufacturing will take time. Companies in LICs and LMICs are hungry to get going. When the WHO recently announced it was seeking LIC/LMIC manufacturers who want to produce mRNA COVID-19 vaccines, it was inundated with proposals. Right now, the world’s scientists and politicians need to pull together to figure out how to get the next steps done. Technology will need to be transferred to a set of potential new producers, which will require experts to be mobilized for this task, many at the originator companies themselves. New financial resources must be mobilized to support building new factories or retrofitting old ones and to coordinate supply chains and other operational tasks at a global scale. The sooner we start, the faster we bring an end to the pandemic.”

***

Comment by Adam Gaffney

Two weeks ago, England saw zero deaths from COVID-19, a testament to the efficacy of vaccines and to the NHS’ efficient vaccination campaign. Similarly, with a majority of its population vaccinated, Israel (but not the neglected Occupied Palestinian Territories) has seen a remarkable retreat of SARS-CoV-2. And the US appears to be following — my state of Massachusetts announced zero COVID deaths on May 10th. Meanwhile, the pandemic is continuing its horrifying course in nations including India and Brazil. Global vaccine apartheid is, in part, to blame for these divergent paths.  

COVID-19 vaccines should have been delivered and distributed, on the basis of need, to every nation on Earth; instead, rich nations (including the US) have signed contracts with pharmaceutical firms allowing them to horde vaccine supplies far in excess of population needs.  

As public health experts Gregg Gonsalves and Gavin Yamey noted in the British Medical Journal, vaccine donations to low-income nations could save lives immediately. However, as they also argue, controlling the pandemic worldwide requires ramping up global production of a “People’s Vaccine” unrestrained by patent protection.  

Intellectual property regimes have long resulted in artificial shortages of needed pharmaceuticals. The COVID-19 pandemic is no exception, but this could have been avoided.  As Physicians for a National Health Program’s 8-point COVID-19 response plan noted more than a year ago,

“…the US should eliminate intellectual property constraints like patents and trade agreements that might restrict the low-cost production and distribution of essential drugs and vaccines, including those developed from publicly-funded research.”

The Biden administration took a step in the right direction last week when it endorsed a waiver of patent rights on COVID-19 vaccines. However, as Gonsalves and Yamey note, this is not enough. While removal of patent protections allows generic drug manufacturers around the globe to cheaply produce small molecule pharmaceutics, the production of more complex biologic agents, including vaccines, additionally requires a transfer of technology, e.g.. the knowhow and trade secrets that go into the production process, as well as financial support. But this is something that we can do — indeed, it should have begun already.

Some have questioned the utility of this approach, or decried “patent busting” more broadly. However, as James Love’s Knowledge Ecology International (KEI) has shown, “companies with pre-existing drug and vaccine manufacturing capabilities can start producing COVID-19 vaccines relatively quickly, if technology transfer is made.” KEI has compiled a database of outsourcing agreements involving technology transfer for COVID-19 vaccine production, and concluded: “In almost all of the cases where information is available the manufacturer said that they were going to make the first delivery, or actually started delivering [vaccines], within six months from the deal announcement date.” 

The lessons to be drawn from this episode should extend beyond the pandemic. A drug development system driven by windfalls from intellectual property ownership is neither just nor efficient — nor is it necessary. We already publicly-fund much of the basic research that underlies drug development; we could publicly-fund the whole pipeline — including clinical trials — as well. As PNHP’s comprehensive pharmaceutical proposal, published in the British Medical Journal in 2018, set forth, we need a path of full public funding of pharmaceutical development by the National Institutes of Health. Such a program would deliver agents that would be in the public domain immediately — for the benefit of the entire global community.

Categories
Uncategorized

Introducing the McCanne Health Justice Monitor

We are excited to bring you the first HJM blog post. Please read on to learn about our mission and (we hope) support us in the fight for achieving health justice.

The COVID-19 pandemic laid bare the inequities, inefficiencies, and fragility of U.S. health care financing. Millions lost job-based health insurance at the same time as they lost income, with people of color and those with the fewest resources hardest hit. According to recent polls, two-thirds of Americans believe that the government has a responsibility to assure health coverage for all. The time is ripe for fundamental health reform, an integral part of the progressive social agenda. 

In pursuit of this vision, we are launching the McCanne Health Justice Monitor, a continuation and expansion of Don McCanne’s Quote of the Day (QOTD). Don single-handedly produced that informative and inspiring daily health policy update for over 20 years. His more than 5000 posts tackled a broad range of health policy issues, always ending with a call to common sense: “Let’s do single payer, already!” (or words to that effect – Don never repeats). Don offered a guide to understanding myriad policy developments as a tool in the pursuit of justice, a goal that can be attained only through single payer reform. Recently, Don chose to step back from his daily labors, and offered his support for our team to build on his efforts. Our debt to Don and our vision for this new undertaking are reflected in our name.

The McCanne Health Justice Monitor will continue and expand the QOTD mission. We will retain a focus on the failings of the U.S. health system and, of course, single payer reform. We expect to increase coverage of other areas vital to a progressive agenda for health, including racism and racial inequities, climate and environmental justice, and the global health injustices affecting low- and middle-income nations. Since no individual could match Don’s efforts, we have assembled a group of health policy experts as core contributors, with each contributing several items per month. We will also feature guest contributors on a broad range of topics.

There is no time like the present to replace the unequal and unjust U.S. health care system with a simple, practical, and humane single payer system. We will endeavor to regularly bring you informed and responsible policy updates and views on how to achieve health justice.